Literature DB >> 9952204

Current and remote blood pressure and cognitive decline.

R J Glynn1, L A Beckett, L E Hebert, M C Morris, P A Scherr, D A Evans.   

Abstract

CONTEXT: Previous studies raise the possibility that blood pressure (BP) in middle age predicts later cognitive decline.
OBJECTIVE: To examine prospectively the relationship of BP with level of and change in cognitive function in the elderly.
DESIGN: Longitudinal, population-based study comprising subjects enrolled in the East Boston component of the Established Populations for the Epidemiologic Study of the Elderly (EPESE) (1982-1983) and the Hypertension Detection and Follow-Up Program (HDFP) (1973-1974).
SETTING: East Boston, Mass. PARTICIPANTS: Of the 3657 participants in the EPESE with baseline BP measurements, 2068 also participated in the HDFP. Subjects were aged 65 to 102 years at baseline in the EPESE and had mental status and memory assessed at baseline and 3 and 6 years. MAIN OUTCOME MEASURES: Numbers of errors on the Short Portable Mental Status Questionnaire and the East Boston Memory Test and rates of change in these numbers of errors. Subjects had BP measured both at baseline in the EPESE and 9 years before, as part of the HDFP.
RESULTS: In analyses adjusted for age, sex, and education, there was no strong linear association between BP and cognition. The associations found were fairly small in magnitude, and varied according to which test was used to measure cognition. There was little evidence for an effect of BP on change in cognitive function with either test, or for an effect on level of function on the memory test. In analyses of level of mental status questionnaire performance, however, elevated systolic BP (> or =160 mm Hg) 9 years before baseline was associated with a 14% (95% confidence interval [CI], 4%-25%) increase in error rate, relative to the referent (130-139 mm Hg). Baseline systolic BP had a U-shaped association with the number of errors; error rates were 9% higher compared with the referent group among those with systolic BP lower than 130 mm Hg (95% CI, 1%-17%) and 7% greater (95% CI, 0%-15%) among those with elevated systolic BP. Diastolic BP 9 years before baseline also had a U-shaped association with errors on the mental status questionnaire.
CONCLUSION: The findings do not suggest a linear association of BP with cognitive decline, but they are consistent with a more complex relationship between BP and cognition than previously appreciated.

Entities:  

Mesh:

Year:  1999        PMID: 9952204     DOI: 10.1001/jama.281.5.438

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  60 in total

Review 1.  Hypertension and dementia.

Authors:  A S Rigaud; O Hanon; M L Seux; F Forette
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 2.  Does the angiotensin II receptor antagonist losartan improve cognitive function?

Authors:  Michele A Tedesco; Gennaro Ratti; Giovanni Di Salvo; Francesco Natale
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health.

Authors:  Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

4.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

Review 5.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

6.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

Review 7.  Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.

Authors:  Paul K Crane; Kaavya Narasimhalu; Laura E Gibbons; Dan M Mungas; Sebastien Haneuse; Eric B Larson; Lewis Kuller; Kathleen Hall; Gerald van Belle
Journal:  J Clin Epidemiol       Date:  2008-05-05       Impact factor: 6.437

8.  Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline.

Authors:  M C Morris; D A Evans; J L Bienias; P A Scherr; C C Tangney; L E Hebert; D A Bennett; R S Wilson; N Aggarwal
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 9.  Hypertension and dementia.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 10.  Alzheimer's disease and endothelial dysfunction.

Authors:  Giuseppe Bomboi; Lorenzo Castello; Francesco Cosentino; Franco Giubilei; Francesco Orzi; Massimo Volpe
Journal:  Neurol Sci       Date:  2009-10-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.